|
"hsiao cf"的相關文件
顯示項目 41-90 / 201 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
| 中山醫學大學 |
2020 |
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
|
Wong, JYY; Zhang, H; Hsiung, CA; Shiraishi, K; Yu, K; Matsuo, K; Wong, MP; Hong, YC; Wang, JC; Seow, WJ; Wang, ZM; Song, MS; Kim, HN; Chang, IS; Chatterjee, N; Hu, W; Wu, C; Mitsudomi, T; Zheng, W; Kim, JH; Seow, A; Caporaso, NE; Shin, MH; Chung, LP; An, SJ; Wang, P; Yang, Y; Zheng, H; Yatabe, Y; Zhang, XC; Kim, YT; Cai, QY; Yin, ZH; Kim, YC; Bassig, BA; Chang, J; Ho, JCN; Ji, BT; Daigo, Y; Ito, H; Momozawa, Y; Ashikawa, K; Kamatani, Y; Honda, T; Hosgood, HD; Sakamoto, H; Kunitoh, H; Tsuta, K; Watanabe, SI; Kubo, M; Miyagi, Y; Nakayama, H; Matsumoto, S; Tsuboi, M; Goto, K; Shi, JX; Song, L; Hua, X; Takahashi, A; Goto, A; Minamiya, Y; Shimizu, K; Tanaka, K; Wei, F; Matsuda, F; Su, J; Kim, YH; Oh, IJ; Song, FJ; Su, WC; Chen, YM; Chang, GC; Chen, KY; Huang, MS; Chien, LH; Xiang, YB; Park, JY; Kweon, SS; Chen, CJ; Lee, KM; Blechter, B; Li, HX; Gao, YT; Qian, BY; Lu, DR; Liu, JJ; Jeon, HS; Hsiao, CF; Sung, JS; Tsai, YH; Jung, YJ; Guo, H; Hu, ZB; Wang, WC; Chung, CC; Burdett, L; Yeager, M; Hutchinson, A; Berndt, SI; Wu, W; Pang, H; Li, YQ; Choi, JE; Park, KH; Sung, SW; Liu, L; Kang, CH; Zhu, M; Chen, CH; Yang, TY; Xu, J; Guan, P; Tan, W; Wang, CL; Hsin, M; Sit, KY; Chen, Y; Choi, YY; Hung, JY; Kim, JS; Il Yoon, H; Lin, CC; Park, IK; Xu, P; Wang, Y; He, Q; Perng, RP; Chen, CY; Vermeulen, R; Wu, JJ; Lim, WY; Chen, KC; Li, YJ; Li, JH; Chen, HY; Yu, CJ; Jin, L; Chen, TY; Jiang, SS; Liu, J; Yamaji, T; Hicks, B; Wyatt, K; Li, SA; Dai, JC; Ma, HX; Jin, GF; Song, B; Wang, ZH; Cheng, SS; Li, XL; Ren, YW; Cui, P; Iwasaki, M; Shimazu, T; Tsugane, S; Zhu, JJ; Yang, KY; Jiang, GN; Fei, K; Wu, GP; Lin, HC; Chen, HL; Fang, YH; Tsai, FY; Hsieh, WS; Yu, JM; Stevens, VL; Laird-Offringa, IA; Marconett, CN; Rieswijk, L; Chao, A; Yang, PC; Shu, XO; Wu, T; Wu, YL; Lin, DX; Chen, KX; Zhou, BS; Huang, YC; Kohno, T; Shen, H; Chanock, SJ; Rothman, N; Lan, Q |
| 國家衛生研究院 |
2019-12-18 |
An open-label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy of TLC388 and genomic analysis for poorly differentiated neuroendocrine carcinomas
|
Chen, MH;Chou, WC;Hsiao, CF;Jiang, SS;Tsai, HJ;Liu, YC;Hsu, C;Shan, YS;Hung, YP;Hsich, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2019-12-17 |
Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model
|
Chien, LH;Chen, CH;Chen, TY;Chang, GC;Tsai, YH;Hsiao, CF;Chen, KY;Su, WC;Wang, WC;Huang, MS;Chen, YM;Chen, CY;Liang, SK;Chen, CY;Wang, CL;Lee, MH;Chung, RH;Tsai, FY;Hu, JW;Katki, HA;Chatterjee, N;Chanock, SJ;Rothman, N;Lan, Q;Yang, PC;Chen, CJ;Chang, IS;Hsiung, CA |
| 國家衛生研究院 |
2019-11-14 |
A multicenter prospective study of first-line antibiotic therapy for early-stage gastric mucosa-associated lymphoid tissue lymphoma and diffuse large B-cell lymphoma with histological evidence of mucosa-associated lymphoid tissue
|
Tsai, HJ;Tai, JJ;Chen, LT;Wu, MS;Yeh, KH;Lin, CW;Wang, TE;Wang, HP;Yu, FJ;Liou, JM;Hsiao, CF;Cheng, TY;Yeh, HJ;Ko, CW;Chen, MJ;Lo, GH;Hsu, PI;Chang, CS;Hwang, WS;Chuang, SS;Lee, HW;Shun, CT;Chiu, CF;Wang, WM;Hsieh, CY;Liu, TW;Lin, JT;Kuo, SH;Cheng, AL |
| 國家衛生研究院 |
2019-07-12 |
Tuberculosis infection and lung adenocarcinoma: Mendelian randomization and pathway analysis of genome-wide association study data from never-smoking Asian women
|
Wong, JYY;Zhang, H;Hsiung, CA;Shiraishi, K;Yu, K;Matsuo, K;Wong, MP;Hong, YC;Wang, J;Seow, WJ;Wang, Z;Song, M;Kim, HN;Chang, IS;Chatterjee, N;Hu, W;Wu, C;Mitsudomi, T;Zheng, W;Kim, JH;Seow, A;Caporaso, NE;Shin, MH;Chung, LP;An, SJ;Wang, P;Yang, Y;Zheng, H;Yatabe, Y;Zhang, XC;Kim, YT;Cai, Q;Yin, Z;Kim, YC;Bassig, BA;Chang, J;Ho, JCM;Ji, BT;Daigo, Y;Ito, H;Momozawa, Y;Ashikawa, K;Kamatani, Y;Honda, T;Hosgood, HD;Sakamoto, H;Kunitoh, H;Tsuta, K;Watanabe, SI;Kubo, M;Miyagi, Y;Nakayama, H;Matsumoto, S;Tsuboi, M;Goto, K;Shi, J;Song, L;Hua, X;Takahashi, A;Goto, A;Minamiya, Y;Shimizu, K;Tanaka, K;Wei, F;Matsuda, F;Su, J;Kim, YH;Oh, IJ;Song, F;Su, WC;Chen, YM;Chang, GC;Chen, KY;Huang, MS;Chien, LH;Xiang, YB;Park, JY;Kweon, SS;Chen, CJ;Lee, KM;Blechter, B;Li, H;Gao, YT;Qian, B;Lu, D;Liu, J;Jeon, HS;Hsiao, CF;Sung, JS;Tsai, YH;Jung, YJ;Guo, H;Hu, Z;Wang, WC;Chung, CC;Burdett, L;Yeager, M;Hutchinson, A;Berndt, SI;Wu, W, .;et al. |
| 國家衛生研究院 |
2019-06-21 |
Cost-effectiveness of preventing hepatitis B virus reactivation in patients with lymphoma and resolved HBV infection
|
Tsou, HH;Yang, HC;Hsiao, CF;Hsiung, CA;Liu, TW;Chuang, MH;Wu, HY;Hsu, YT;Tsui, CW;Chen, PJ;Cheng, AL;Hsu, C; the Taiwan Cooperative Oncology Group |
| 國家衛生研究院 |
2019-05 |
An open label, single-arm, two-stage, multicenter, phase II study to evaluate the efficacy and safety of TLC388 as second-line treatment in subjects with poorly differentiated neuroendocrine carcinomas (TCOGT1Z14)
|
Chen, MH;Chou, WC;Hsiao, CF;Liu, YC;Hsu, C;Yanshen, S;Hung, YP;Hsieh, CH;Chiu, CH;Liu, TC;Cho, SF;Liu, TW;Chao, Y |
| 國家衛生研究院 |
2018-08-21 |
Design and data analysis of multiregional clinical trials (MRCTs)—Theory and practice
|
Chen, CT;Tsou, HH;Liu, JT;Hsiao, CF;Chen, F;Li, G;Lan, KKG |
| 國家衛生研究院 |
2018-07-17 |
Final results of a randomized phase III trial of induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in patients with stage IVA and IVB nasopharyngeal carcinoma-Taiwan Cooperative Oncology Group (TCOG)
|
Hong, RL;Hsiao, CF;Ting, LL;Ko, JY;Wang, CW;Chang, JTC;Lou, PJ;Wang, HM;Tsai, MH;Lai, SC;Liu, TW |
| 國家衛生研究院 |
2018-04-07 |
The clinical impact of the novel tumor marker DR-70 in unresectable gastric cancer patients
|
Hung, YP;Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2018-01-01 |
Use of interval estimations in design and evaluation of multiregional clinical trials with continuous outcomes
|
Chiang, C;Hsiao, CF |
| 國家衛生研究院 |
2017-11-23 |
Prediction of plasma efavirenz concentrations among HIV-positive patients taking efavirenz-containing combination antiretroviral therapy
|
Huang, SH;Lin, SW;Chang, SY;Lin, YT;Chiang, C;Hsiao, CF;Sun, HY;Liu, WC;Su, YC;Hung, CC;Chang, SC |
| 國家衛生研究院 |
2017-11 |
Intake of potassium- and magnesium-enriched salt improves functional outcome after stroke: A randomized, multicenter, double-blind controlled trial
|
Pan, WH;Lai, YH;Yeh, WT;Chen, JR;Jeng, JS;Bai, CH;Lin, RT;Lee, TH;Chang, KC;Lin, HJ;Hsiao, CF;Chern, CM;Lien, LM;Liu, CH;Chen, WH;Chang, A |
| 國家衛生研究院 |
2017-10 |
Differences in health-related quality of life between European and Asian patients with hepatocellular carcinoma
|
Chie, WC;Blazeby, JM;Hsiao, CF;Chiu, HC;Poon, RT;Mikoshiba, N;Al-Kadhim, G;Heaton, N;Calara, J;Collins, P;Caddick, K;Costantini, A;Vilgrain, V;Chiang, C;Group, EOTRC Quality of Life |
| 國家衛生研究院 |
2017-09 |
A tolerance interval approach to assessing the biosimilarity of follow-on biologics
|
Chen, CT;Tsou, HH;Hsiao, CF;Lai, YH;Chang, WJ;Liu, JT |
| 國家衛生研究院 |
2017-08-30 |
Use of a Bayesian approach in the design and evaluation of NCE2s
|
Wang, CY;Chang, LC;Lin, MS;Hsiao, CF;Huang, JD |
| 國家衛生研究院 |
2017-06-30 |
Sample size determination for a specific region in multiregional clinical trials with multiple co-primary endpoints
|
Huang, WS;Hung, HN;Hamasaki, T;Hsiao, CF |
| 國家衛生研究院 |
2017-05 |
Efficient group-sequential designs for monitoring two time-to-event outcomes in clinical trials
|
Hamasaki, T;Asakura, K;Sugimoto, T;Evans, SR;Yamamoto, H;Hsiao, CF |
| 國家衛生研究院 |
2017-03 |
Genetic modifiers of progression-free survival in never-smoking lung adenocarcinoma patients treated with first-line TKIs
|
Chang, IS;Jiang, SS;Yang, JC;Su, WC;Chien, LH;Hsiao, CF;Lee, JH;Chen, CY;Chen, CH;Chang, GC;Wang, Z;Lo, FY;Chen, KY;Wang, WC;Chen, YM;Huang, MS;Tsai, YH;Su, YC;Hsieh, WS;Shih, WC;Shieh, SH;Yang, TY;Lan, Q;Rothman, N;Chen, CJ;Chanock, SJ;Yang, PC;Hsiung, CA |
| 國家衛生研究院 |
2017-03 |
An approach for sample size determination of average bioequivalence based on interval estimation
|
Chiang, C;Hsiao, CF |
| 國家衛生研究院 |
2017-02 |
Integrated care for geriatric frailty and sarcopenia: A randomized control trial
|
Chan, DCD;Tsou, HH;Chang, CB;Yang, RS;Tsauo, JY;Chen, CY;Hsiao, CF;Hsu, YT;Chen, CH;Chang, SF;Hsiung, CA;Kuo, KN |
| 國家衛生研究院 |
2016-11-11 |
Assessing benefit and consistency of treatment effect under a discrete random effects model in multiregional clinical trials
|
Liu, JT;Chen, CT;Lan, KKG;Tzeng, CS;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2016-10 |
The role of pre-treatment plasma Epstein-Barr virus (EBV) DNA as a predictive biomarker of induction chemotherapy for stage IVA or IVB nasopharyngeal carcinoma (NPC) patients - A Subgroup Analysis on Taiwan Cooperative Oncology Group (TCOG) 1303 study
|
Kao, HF;Hsiao, CF;Lai, SC;Wang, CW;Ko, JY;Lo, PJ;Lee, TJ;Liu, TW;Hong, RL |
| 國家衛生研究院 |
2016-06 |
Assessing the consistency of the treatment effect under the discrete random effects model in multiregional clinical trials
|
Liu, JT;Tsou, HH;Gordon Lan, KK;Chen, CT;Lai, YH;Chang, WJ;Tzeng, CS;Hsiao, CF |
| 國家衛生研究院 |
2016-04-21 |
The discrete random-effects model-assessing benefit and consistency of treatment effect
|
Tsou, HH;Lan, KKG;Liu, JT;Hsiao, CF |
| 國家衛生研究院 |
2016-01 |
A phase II study of sequential capecitabine plus oxaliplatin followed by docetaxel plus capecitabine in patients with unresectable gastric adenocarcinoma: The TCOG 3211 clinical trial
|
Chen, MH;Lin, J;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-12 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma-TCOG 3211 clinical trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-10 |
Quality of life changes in patients undergoing treatment for hepatocellular carcinoma
|
Chie, WC;Yu, F;Li, M;Baccaglini, L;Blazeby, JM;Hsiao, CF;Chiu, HC;Poon, RT;Mikoshiba, N;Al-Kadhimi, G;Heaton, N;Calara, J;Collins, P;Caddick, K;Costantini, A;Vilgrain, V;Chiang, C |
| 國家衛生研究院 |
2015-10 |
Estrogen receptor gene polymorphisms and lung adenocarcinoma risk in never-smoking women
|
Chen, KY;Hsiao, CF;Chang, GC;Tsai, YH;Su, WC;Chen, YM;Huang, MS;Tsai, FY;Jiang, SS;Chang, IS;Chen, CY;Hsiung, CA;Chen, CJ;Yang, PC |
| 國家衛生研究院 |
2015-09-01 |
Chemokine IP-10 is correlated with cardiac responses and status of infection with HIV and HCV in methadone maintenance patients
|
Liu, SW;Liu, YL;Hwang, LL;Wang, SC;Kuo, HW;Wu, SL;Dai, YWE;Liu, SC;Ho, IK;Chen, ACH;Hsiao, CF;Tsou, HH |
| 國家衛生研究院 |
2015-07 |
Genetic variants associated with longer telomere length are associated with increased lung cancer risk among never-smoking women in Asia: A report from the female lung cancer consortium in Asia
|
Machiela, MJ;Hsiung, CA;Shu, XO;Seow, WJ;Wang, Z;Matsuo, K;Hong, YC;Seow, A;Wu, C;Hosgood, HD;Chen, K;Wang, JC;Wen, W;Cawthon, R;Chatterjee, N;Hu, W;Caporaso, NE;Park, JY;Chen, CJ;Kim, YH;Kim, YT;Landi, MT;Shen, H;Lawrence, C;Burdett, L;Yeager, M;Chang, IS;Mitsudomi, T;Kim, HN;Chang, GC;Bassig, BA;Tucker, M;Wei, F;Yin, Z;An, SJ;Qian, B;Lee, VHF;Lu, D;Liu, J;Jeon, HS;Hsiao, CF;Sung, JS;Kim, JH;Gao, YT;Tsai, YH;Jung, YJ;Guo, H;Hu, Z;Hutchinson, A;Wang, WC;Klein, RJ;Chung, CC;Oh, IJ;Chen, KY;Berndt, SI;Wu, W;Chang, J;Zhang, XC;Huang, MS;Zheng, H;Wang, J;Zhao, X;Li, Y;Choi, JE;Su, WC;Park, KH;Sung, SW;Chen, YM;Liu, L;Kang, CH;Hu, L;Chen, CH;Pao, W;Kim, YC;Yang, TY;Xu, J;Guan, P;Tan, W;Su, J;Wang, CL;Li, H;Sihoe, ADL;Zhao, Z;Chen, Y;Choi, YY;Hung, JY;Kim, JS;Yoon, HI;Cai, Q;Lin, CC;Park, IK;Xu, P;Dong, J;Kim, C;He, Q;Perng, RP;Kohno, T;Kweon, SS;Chen, CY;Vermeulen, RCH,.;et al. |
| 國家衛生研究院 |
2015-05 |
Randomized, phase III trial of adjuvant adeforvir vs. therapeutic lamivudine in post-operative BCLC stage 0 or A HBV-related HCC: The Taiwan Cooperative Oncology Group T1206 study
|
Chen, LT;Jeng, LB;Hsiao, CF;Wu, CC;Lee, WC;Wang, TE;Lee, PH;Chen, CL;Chen, IS;Lee, KT;Hsieh, CB;Hwang, WS;Yang, MD;Yang, YS;Lin, DY;Chen, MF;Chen, PJ;Taiwan Cooperative Oncology, G |
| 國家衛生研究院 |
2015-05 |
A phase II study of sequential capecitabine plus oxaliplatin (XELOX) followed by docetaxel plus capecitabine (TX) in patients with unresectable gastric adenocarcinoma: The TCOG T3211 trial
|
Chen, MH;Lin, JS;Hsiao, CF;Shan, YS;Chen, YC;Chen, LT;Liu, TW;Li, CP;Chao, Y |
| 國家衛生研究院 |
2015-03 |
Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)
|
Hosgood, HD;Song, MS;Hsiung, CA;Yin, ZH;Shu, XO;Wang, ZM;Chatterjee, N;Zheng, W;Caporaso, N;Burdette, L;Yeager, M;Berndt, SI;Landi, MT;Chen, CJ;Chang, GC;Hsiao, CF;Tsai, YH;Chien, LH;Chen, KY;Huang, MS;Su, WC;Chen, YM;Chen, CH;Yang, TY;Wang, CL;Hung, JY;Lin, CC;Perng, RP;Chen, CY;Chen, KC;Li, YJ;Yu, CJ;Chen, YS;Chen, YH;Tsai, FY;Kim, C;Seow, WJ;Bassig, BA;Wu, W;Guan, P;He, QC;Gao, YT;Cai, QY;Chow, WH;Xiang, YB;Lin, DX;Wu, C;Wu, YL;Shin, MH;Hong, YC;Matsuo, K;Chen, KX;Wong, MP;Lu, DR;Jin, L;Wang, JC;Seow, A;Wu, TC;Shen, HB;Fraumeni, JF;Yang, PC;Chang, IS;Zhou, BS;Chanock, SJ;Rothman, N;Lan, Q |
| 國立交通大學 |
2014-12-08T15:19:24Z |
Colonization of human immunodeficiency virus-infected outpatients in Taiwan with Candida species
|
Hung, CC; Yang, YL; Lauderdale, TL; McDonald, LC; Hsiao, CF; Cheng, HH; Ho, YA; Lo, HJ |
| 國家衛生研究院 |
2014-10-13 |
Sample size determination for individual bioequivalence inference
|
Chiang, C;Hsiao, CF;Liu, JP |
| 國家衛生研究院 |
2014-10 |
Use of a bayesian approach to design and evaluation of NCE2
|
Chang, LC;Yeh, MK;Lin, MS;Hsiao, CF |
| 國家衛生研究院 |
2014-09 |
The effect of intervention with potassium and magnesium-enriched salt on neurological performance in stroke patients
|
Lai, YH;Chen, JR;Jeng, JS;Chen, CM;Bai, CH;Lin, RT;Lee, TH;Chang, KC;Lin, HJ;Hsiao, CF;Chern, CM;Lien, LM;Liu, CH;Pan, WH |
| 國家衛生研究院 |
2014-06-02 |
Insulin Resistance: Regression and clustering
|
Yoon, S;Assimes, TL;Quertermous, T;Hsiao, CF;Chuang, LM;Hwu, CM;Rajaratnam, B;Olshen, RA |
| 國家衛生研究院 |
2014-05 |
Celecoxib plus chemoradiotherapy for locally advanced rectal cancer: A phase II TCOG study
|
Wang, LW;Hsiao, CF;Chen, WTL;Lee, HH;Lin, TC;Chen, HC;Chen, HH;Chien, CR;Lin, TY;Liu, TW |
| 國家衛生研究院 |
2014-04 |
The association of genetic polymorphisms in the kappa-opioid receptor 1 gene with body weight, alcohol use, and withdrawal symptoms in patients with methadone maintenance
|
Wang, SC;Tsou, HH;Chung, RH;Chang, YS;Fang, CP;Chen, CH;Ho, IK;Kuo, HW;Liu, SC;Shih, YH;Wu, HY;Huang, BH;Lin, KM;Chen, AC;Hsiao, CF;Liu, YL |
| 國家衛生研究院 |
2014-04 |
Prevention of chemotherapy-induced hbv-related hepatitis flare in lymphoma patients with resolved hbv infection: Cost analysis
|
Tsou, HH;Yang, HC;Chuang, MH;Wu, HY;Hsu, YT;Chang, WJ;Hsiao, CF;Hsu, C;Grp, Taiwan Cooperative Oncology |
| 國家衛生研究院 |
2014-03 |
Sample size determination for within-device precision
|
Chiang, C;Hsiao, CF;Liu, JP |
| 國家衛生研究院 |
2014-03 |
Sample size estimation of multiregional clinical trials with heterogeneous variability across regions
|
Wu, YJ;Tan, TS;Chow, SC;Hsiao, CF |
| 國家衛生研究院 |
2013-11-28 |
Endothelin type A receptor genotype is a determinant of quantitative traits of metabolic syndrome in Asian hypertensive families: A SAPPHIRe study
|
Ho, LT;Hsu, YP;Hsiao, CF;Ting, CT;Shih, KC;Chuang, LM;Masaki, K;Grove, J;Quertermous, T;Juan, CC;Lin, MW;Chiang, SC;Chen, YD |
| 國家衛生研究院 |
2013-11 |
Comparison of escitalopram and paroxetine in the treatment of major depressive disorder
|
Lin, HL;Hsu, YT;Liu, CY;Chen, CH;Hsiao, MC;Liu, YL;Shen, WW;Hsiao, CF;Liu, SI;Chang, LH;Tang, HS;Lai, HL;Lin, PS;Lin, KM;Tsou, HH |
| 國家衛生研究院 |
2013-09 |
Functional genetic polymorphisms in CYP2C19 Gene in relation to cardiac side effects and treatment dose in a methadone maintenance cohort
|
Wang, SC;Ho, IK;Tsou, HH;Liu, SW;Hsiao, CF;Chen, CH;Tan, HK;Lin, L;Wu, CS;Su, LW;Huang, CL;Yang, YH;Liu, ML;Lin, KM;Liu, SC;Wu, HY;Kuo, HW;Chen, AC;Chang, YS;Liu, YL |
| 國家衛生研究院 |
2013-09 |
Use of random effect models in the design and analysis of multi-regional clinical trials
|
Wu, YJ;Tan, TS;Chow, SC;Hsiao, CF |
| 國家衛生研究院 |
2013-07 |
CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions
|
Kuo, HW;Liu, SC;Tsou, HH;Liu, SW;Lin, KM;Lu, SC;Hsiao, MC;Hsiao, CF;Liu, CY;Chen, CH;Lu, ML;Shen, WW;Tang, HS;Liu, SI;Chang, LH;Wu, HY;Chang, YS;Yeh, TK;Chen, AC;Liu, YL |
| 國家衛生研究院 |
2013-05 |
Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy
|
Chang, CH;Hsiao, CF;Yeh, YM;Chang, GC;Tsai, YH;Chen, YM;Huang, MS;Chen, HL;Li, YJ;Yang, PC;Chen, CJ;Hsiung, CA;Su, WC |
顯示項目 41-90 / 201 (共5頁)
1 2 3 4 5 > >>
每頁顯示[10|25|50]項目
|
